Alterations in the human plasma lipidome in response to Tularemia vaccination
Authors:
- Kristal M. Maner-SmithKMKristal M. Maner-Smith
- David A. FordDFDavid A. Ford
- Johannes B. GollJGJohannes B. Goll
- Travis L. JensenTJTravis L. Jensen
- Manoj KhadkaMKManoj Khadka
- Jennifer K. ColucciJCJennifer K. Colucci
- Casey E. GelberCGCasey E. Gelber
- Carolyn J. AlbertCACarolyn J. Albert
- Steven E. BosingerSBSteven E. Bosinger
- Jacob D. FrankeJFJacob D. Franke
- Muktha NatrajanMNMuktha Natrajan
- Nadine RouphaelNRNadine Rouphael
Preprint
Abstract
Tularemia is a rare but highly contagious and potentially fatal disease caused by bacteria Francisella tularensis where as few as ten inhaled organisms can lead to an infection, making it one of the most infectious microorganisms known and a potential bioweapon. To better understand the response to a live, attenuated tularemia vaccine and the biological pathways altered post-vaccination, healthy adults were vaccinated by scarification and plasma was collected pre- and post-vaccination for longitudinal lipidomics studies. Using tandem mass spectrometry, we identified and quantified individual lipid molecular species within representative lipid classes in plasma to characterize alterations in the plasma lipidome during the vaccine response. Separately, we targeted oxylipins, a subset of lipid mediators involved in inflammatory pathways. We identified 14 differentially abundant lipid species from eight lipid classes. These included 5-Hydroxyeicosatetraenoic acid (5-HETE), an eicosanoid produced following arachidonic acid liberation and epoxygenation, which is indicative of lipoxygenase activity and, subsequently, inflammation. Results suggest that 5-HETE was metabolized to a dihydroxyeicosatrienoic acid (DHET) by Day 7 post-vaccination, shedding light on the kinetics of the 5-HETE-mediated inflammatory response. In addition to 5-HETE and DHET, we observed pronounced changes in 34:1 phosphatidylinositol, anandamide, oleamide, ceramides, 16:1 cholesteryl ester, and several glycerophospholipids, several of these changes in abundance were correlated with serum cytokines and T cell activation. These data provide new insights into alterations in plasma lipidome post tularemia vaccination, potentially identifying key mediators and pathways involved in vaccine response and efficacy.Keywords
All Related Versions
- Published version: Vaccines, 8 (3), 414.
This publication has 39 references indexed in Scilit:
- Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in HumansCell, 2019
- Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical TrialVaccine, 2017
- Host Cell Phosphatidylcholine Is a Key Mediator of Malaria Parasite Survival during Liver Stage InfectionCell Host & Microbe, 2014
- A Randomized, Double-Blind, Controlled Trial of the 17D Yellow Fever Virus Vaccine Given in Combination with Immune Globulin or Placebo: Comparative Viremia and ImmunogenicityThe American Journal of Tropical Medicine and Hygiene, 2013
- Fundamentals of Vaccine ImmunologyJournal of Global Infectious Diseases, 2011
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humansNature Immunology, 2008
- Lipidomics of host–pathogen interactionsFEBS Letters, 2006
- Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatizationJournal of Lipid Research, 2005
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959
- Deer-Fly Fever, or Pahvant Valley Plague: A Disease of Man of Hitherto Unknown EtiologyPublic Health Reports (1896-1970), 1919